ELElliot Hwejoon Lee

Elliot Hwejoon Lee

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Elliot Hwejoon Lee has a total of 49 co-authors. Here are the top co-authors by number of shared publications:

  • Soo-Jin Oh

    Brain Science Institute Korea Institute of Science and Technology Seoul Republic of Korea

    2 shared publications
  • Ae Nim Pae

    Korea Institute of Science and Technology

    1 shared publication
  • Ambily Viswanath

    Korea University of Science and Technology

    1 shared publication
  • Areum Hwangbo

    Department of Biotechnology, College of Life Science and Biotechnology, Yonsei University, Seoul, 03722, Republic of Korea

    1 shared publication
  • Bonggi Lee

    Department of Food Science and Nutrition, Pukyong National University, Busan, 48513, Republic of Korea; Department of Smart Green Technology Engineering, Pukyong National University, 599-1, Daeyeondong, Nam-gu, Busan, 48513, Republic of Korea; Division of Biomedical Engineering and Research Center for Marine Integrated Bionics Technology, Pukyong National University, Busan, Republic of Korea

    1 shared publication
  • Bongjin Moon

    Sogang Daehakgyo

    1 shared publication

Latest Publications

  • Open Access

    Developmentally Guided Differentiation of Ventral Midbrain Dopaminergic Cells Validated in Proteopathy‐Based Parkinson's Disease Models

    by Heechang Moon, Heejeong Kim, Elliot H. Lee, Hanseul Kim, Ji Hun Kim, Huisu Jeong, Jiwon Cheon, Ga Ram Jeong, Byoung Dae Lee, Jae‐Won Cho, et al.

    Parkinson's disease (PD) involves progressive degeneration of nigrostriatal ventral midbrain dopaminergic (vmDA) neurons and Lewy body proteopathy, necessitating scalable, lineage‐faithful donor cells. However, variability in human pluripotent stem cell (hPSC) differentiation and incomplete ventral midbrain identity limit translational use. Here, we establish a developmentally guided differentiation protocol that reproducibly specifies EN1‐positive vmDA progenitors through temporally optimized SHH, WNT/β‐catenin, and FGF8 signaling. The resulting progenitors mature into vmDA neurons exhibiting stimulus‐dependent dopamine release and maturation‐associated pacemaking activity. Progenitors can be cryopreserved at a defined stage while retaining viability and neurogenic capacity. Functional validation was performed using complementary proteopathy‐based PD models. In vitro, optogenetic induction of α‐synuclein aggregation ( OASIS ) triggered robust aggregate formation and selective degeneration of TH‐positive vmDA neurons in both two‐dimensional cultures and three‐dimensional neurospheroids. In vivo, we established a conditional β23 proteopathy‐based PD mouse model exhibiting progressive nigrostriatal degeneration and motor impairment. Transplantation of hESC‐derived vmDA progenitors into advanced‐stage PD mice led to graft survival, differentiation into vmDA neurons, and significant motor improvement. Together, these findings define a robust vmDA differentiation framework validated across proteopathy‐based disease modeling and transplantation contexts, supporting its application in PD modeling and cell therapy.

  • Neuroprotective effects of Gnetin H from Paeonia lactiflora via CREB-BDNF pathway restoration in a scopolamine-induced memory deficit model

    by June Hee Kim, Seong-Seop Kim, Elliot Hwejoon Lee, Soo-Jin Oh, Gyu-Sang Hong, Bonggi Lee, Ik-Hyun Cho, Chun Whan Choi, Taek Kang, Min Soo Kim

  • Open Access

    Novel potent blockers for TWIK-1/TREK-1 heterodimers as potential antidepressants

    by Elliot Lee, Jung-Eun Park, Young-Eun Han, Ambily Viswanath, Lizaveta Gotina, Yoonjeong Cho, Bongjin Moon, Jin-Young Hwang, Woo Kyu Park, Seonguk Yoo, et al.

    Background and Purpose: TREK-1 (TWIK-related potassium channel-1) is a subunit of the two-pore domain potassium (K2p) channel and is widely expressed in the brain. TREK-1 knockout mice were shown to have antidepressant-like effects, providing evidence for the channel’s potential as a therapeutic target. However, currently there is no good pharmacological inhibitor specifically targeting TREK-1 containing K2p channels that also displays similar antidepressant-like effects. Experimental Approach: We sought to find selective and potent inhibitors for TREK-1 related dimers both in vitro and in vivo. We synthesized and evaluated 2-hydroxy-3-phenoxypropyl piperidine derivatives yielding a library from which many TREK-1 targeting candidates emerged. Key Results: Hydroxyl-phenyl- (2a), piperidino- (2g), and pyrrolidino- (2h) piperidinyl substituted compounds showed high potencies to TREK-1 homodimers with significant antidepressant-like effects in forced swim test and tail suspension test. Interestingly, these compounds were found to have high potencies to TWIK-1/TREK-1 heterodimers, contrastingly, difluoropiperidinyl-4-fluorophenoxy (3e) and 4-hydroxyphenyl-piperidinyl-4-fluorophenoxy (3j) compounds had high potencies to TREK-1 homodimer but lower potency to TWIK-1/TREK-1 heterodimers without significant antidepressant-like effects. We observed positive correlation between inhibition potency to TWIK-1/TREK-1 and immobility time, and no correlation between inhibition potency to TREK-1 homodimer and immobility time. This was consistent with molecular docking simulations of selected compounds to TREK-1 homodimeric and TWIK-1/TREK-1 heterodimeric models. Existing antidepressant fluoxetine was also found to potently inhibit TWIK-1/TREK-1 heterodimers. Conclusion and Implications: Our study reveals novel potent TWIK-1/TREK-1 inhibitors 2a, 2g, and 2h as potential antidepressants and suggest that the TWIK-1/TREK-1 heterodimer could be a potential novel molecular therapeutic target for antidepressants.

  • Open Access

    Long-term Intracellular Recording of Optogenetically-induced Electrical Activities using Vertical Nanowire Multi Electrode Array

    by Jisoo Yoo, Hankyul Kwak, Juyoung Kwon, Go Eun Ha, Elliot H. Lee, Seungwoo Song, Jukwan Na, Hyo-Jung Lee, Jaejun Lee, Areum Hwangbo, et al.

    Continuous recording of intracellular activities in single cells is required for deciphering rare, dynamic and heterogeneous cell responses, which are missed by population or brief single-cell recording. Even if the field of intracellular recording is constantly proceeding, several technical challenges are still remained to conquer this important approach. Here, we demonstrate long-term intracellular recording by combining a vertical nanowire multi electrode array (VNMEA) with optogenetic stimulation to minimally disrupt cell survival and functions during intracellular access and measurement. We synthesized small-diameter and high-aspect-ratio silicon nanowires to spontaneously penetrate into single cells, and used light to modulate the cell’s responsiveness. The light-induced intra- and extracellular activities of individual optogenetically-modified cells were measured simultaneously, and each cell showed distinctly different measurement characteristics according to the cell-electrode configuration. Intracellular recordings were achieved continuously and reliably without signal interference and attenuation over 24 hours. The integration of two controllable techniques, vertically grown nanowire electrodes and optogenetics, expands the strategies for discovering the mechanisms for crucial physiological and dynamic processes in various types of cells.